NOTV

Inotiv Inc

NOTV, USA

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. It operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.

https://www.inotiv.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
NOTV
stock
NOTV

Inotiv, Inc. and VUGENE Announce Strategic Collaboration to Enhance AI-Assisted Drug Discovery and Data Insights Quiver Quantitative

Read more →
NOTV
stock
NOTV

Inotiv (NASDAQ: NOTV) and VUGENE align on AI drug discovery, bioinformatics push Stock Titan

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-06-30)

Rating:

BUY

Target Price:

$5.5

Analyst Picks

Strong Buy

2

Buy

0

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-06-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.18

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-12.22 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-2.31 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-8.76 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

4.28

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 25.47% of the total shares of Inotiv Inc

1.

Balyasny Asset Management LLC

(4.8163%)

since

2025/06/30

2.

Vanguard Group Inc

(4.0281%)

since

2025/06/30

3.

Vanguard Total Stock Mkt Idx Inv

(2.5877%)

since

2025/07/31

4.

Renaissance Technologies Corp

(1.1583%)

since

2025/06/30

5.

Vantage Point Financial LLC

(0.9796%)

since

2025/06/30

6.

Vanguard Institutional Extnd Mkt Idx Tr

(0.9756%)

since

2025/07/31

7.

Geode Capital Management, LLC

(0.9531%)

since

2025/06/30

8.

UBS Group AG

(0.8098%)

since

2025/06/30

9.

Millennium Management LLC

(0.8054%)

since

2025/06/30

10.

Susquehanna International Group, LLP

(0.6815%)

since

2025/06/30

11.

Morgan Stanley - Brokerage Accounts

(0.6386%)

since

2025/06/30

12.

BlackRock Inc

(0.6194%)

since

2025/06/30

13.

Thurston Springer Miller Herd & Titak Inc

(0.5173%)

since

2025/06/30

14.

Kpp Advisory Services LLC

(0.5145%)

since

2025/06/30

15.

Fidelity Extended Market Index

(0.4772%)

since

2025/07/31

16.

ACORN CREEK CAPITAL LLC

(0.4621%)

since

2025/06/30

17.

Mt Lucas Management LP

(0.4177%)

since

2025/06/30

18.

FourWorld Capital Management LLC

(0.4115%)

since

2025/06/30

19.

Citadel Advisors Llc

(0.3809%)

since

2025/06/30

20.

Jane Street Group LLC

(0.3733%)

since

2025/06/30

21.

State Street Corp

(0.3613%)

since

2025/06/30

22.

Marshall Wace Asset Management Ltd

(0.3562%)

since

2025/06/30

23.

Mariner Wealth Advisors LLC

(0.3517%)

since

2025/06/30

24.

Invesco RAFI US 1500 Small-Mid ETF

(0.2182%)

since

2025/08/29

25.

Fidelity Total Market Index

(0.1661%)

since

2025/07/31

26.

Arrow Long/Short Alt Cl F

(0.1644%)

since

2025/08/31

27.

iShares Micro-Cap ETF

(0.145%)

since

2025/08/31

28.

Fidelity Series Total Market Index

(0.1256%)

since

2025/07/31

29.

Avantis US Small Cap Equity ETF

(0.1123%)

since

2025/08/30

30.

Northern Trust Extended Eq Market Idx

(0.1059%)

since

2025/06/30

31.

NT Ext Equity Mkt Idx Fd - L

(0.1059%)

since

2025/06/30

32.

Spartan Extended Market Index Pool F

(0.1048%)

since

2025/07/31

33.

Arrow Opportunities Alternative Fund F

(0.1011%)

since

2025/08/31

34.

Extended Equity Market Fund K

(0.0976%)

since

2025/06/30

35.

NT Ext Equity Mkt Idx Fd - NL

(0.0844%)

since

2025/06/30

36.

NT Ext Equity Mkt Idx Fd - DC - NL - T2

(0.0656%)

since

2025/06/30

37.

Spartan Total Market Index Pool G

(0.0626%)

since

2025/07/31

38.

Frontegra Small Cap Core Fund

(0.0473%)

since

2024/12/31

39.

Schwab Total Stock Market Index

(0.0437%)

since

2025/07/31

40.

FTSE RAFI US 1500 Mid Small Index Fd F

(0.0428%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.51

Latest Release

Date

2025-09-30

EPS Actual

0

EPS Estimate

-0.3322

EPS Difference

0.3322

Surprise Percent

100%

Investing Fit Scorecard

(Last Updated 2025-06-30)

Deep Value
Potential Value Candidate(4.5)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(3.8)
GARP
Not Attractive for GARP(1.5)
Growth
Weak Growth Prospect(1.5)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(1)
Quality
Low Quality Business(1.5)
Value
Fair Value(4)

Income Statement

(Last Updated 2025-06-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-06-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-06-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.